Mouse livers were engineered via a one-time genome editing to secrete a GLP-1, cutting weight gain and improving glucose ...

University of Osaka researchers used genome editing to program mouse liver cells to produce exenatide, a weight-loss drug.

Indian pharma powers ahead with research on NDDS for painless, precision medicine delivery: Nandita Vijayasimha, Bengaluru Thursday, July 10, 2025, 08:00 Hrs [IST] Indian pharma i ...

Erythrocyte-Membrane-Enveloped Biomineralized Metal–Organic Framework Nanoparticles Enable Intravenous Glucose-Responsive Insulin Delivery Article link copied! Mengyun He Mengyun He State Key ...

Case Western Reserve University chemist Divita Mathur was awarded a National Science Foundation (NSF) Faculty Early Career ...

Q: I have been caring for my 75-year-old husband with dementia for the past four years (I am 72), and I’m at my wits’ end.

It is the first biosimilar of a rapid-acting insulin product – used to control the blood glucose spike after meals – and only the third insulin biosimilar to be approved in the US.

FDA rejects Novo Nordisk’s once-weekly basal insulin for people with diabetes, which would reduce the number of injections needed.